Page last updated: 2024-11-02

oxophenylarsine and Hyperkalemia

oxophenylarsine has been researched along with Hyperkalemia in 1 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, RM1
Wei, Y1
Falck, JR1
Krishna, UM1
Wang, WH1

Other Studies

1 other study available for oxophenylarsine and Hyperkalemia

ArticleYear
Effects of protein tyrosine kinase and protein tyrosine phosphatase on apical K(+) channels in the TAL.
    American journal of physiology. Cell physiology, 2001, Volume: 281, Issue:4

    Topics: Amides; Animals; Arsenicals; Benzoquinones; CSK Tyrosine-Protein Kinase; Enzyme Inhibitors; Female;

2001